menu search

Allakos presents preclinical data at eaaci hybrid congress 2023 highlighting lirentelimab and ak006 mechanisms of mast cell inhibition

– AK006 inhibits IgE mediated mast cell activation and shows similar IgE inhibitory activity as remibrutinib –– AK006 also inhibits non-IgE mast...

June 12, 2023, 11:02 am

Atossa finishes pk run-in cohort enrollment in breast cancer trial

Atossa Therapeutics Inc (NASDAQ:ATOS), which is developing medicines aimed at oncology and breast cancer, revealed that the pharmacokinetic (PK) run-i...

June 12, 2023, 10:52 am

Immunocore holdings: unlocking the immune system's hidden potential

Immunocore Holdings is a leading biotech firm with a promising pipeline of T cell receptor-based bispec...

June 11, 2023, 3:49 am

Biora therapeutics to present preclinical data on the biojet™ systemic oral delivery platform at the 59th annual meeting of the european association for the study of diabetes

SAN DIEGO, June 08, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, to...

June 8, 2023, 9:00 am

Anavex's blarcamesine: sigma-1 receptor agonists and antioxidants for alzheimer's disease

Blarcamesine, a sigma-1 receptor agonist, may be a more effective antioxidant than Aricept and galantam...

June 6, 2023, 9:00 pm

Allakos announces upcoming presentation on lirentelimab and ak006 mast cell inhibition at the european academy of allergy and clinical immunology (eaaci) hybrid congress 2023

SAN CARLOS, Calif., June 05, 2023 (GLOBE NEWSWIRE) — Allakos Inc. (Nasdaq: ALLK), a clinical-stage biotechnology company developing therapeutics whi...

June 5, 2023, 11:02 am

Tscan therapeutics announces pricing of $140 million public offering

WALTHAM, Mass., May 26, 2023 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the d...

May 26, 2023, 4:37 am

Cvrx to present at the william blair 43rd annual growth stock conference

MINNEAPOLIS, May 25, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing,...

May 25, 2023, 8:30 am

Pfizer has the prescription for higher share prices

Pfizer Inc. NYSE: PFE released the results of a peer review study that sent shares up more than 5%. The study evaluated the company's GLP-1 ...

May 25, 2023, 7:01 am

Innovative cellular therapeutics (ict) presented data at the american society of gene and cell therapy (asgct) 26th annual meeting

ROCKVILLE, Md., May 24, 2023 (GLOBE NEWSWIRE) — Innovative Cellular Therapeutics, Inc. (ICT), a clinical-stage biotechnology company developing a co...

May 24, 2023, 12:00 pm

Exscientia's ai-powered drug discovery platform is the future of precision medicine

Exscientia's AI-driven drug discovery platform has positioned the company at the forefront of precision medicine, revolutionizing the way new therapie...

May 18, 2023, 1:44 am

Immunic notes neuroprotective potential of vidofludimus calcium highlighted in preclinical data

Immunic Inc (NASDAQ:IMUX) has announced the publication of preclinical data highlighting the neuroprotective potential of its investigational drug, v...

May 17, 2023, 8:21 am

Celldex therapeutics presents positive preclinical data from tslp/scf bispecific antibody program cdx-622 at immunology2023™

HAMPTON, N.J., May 15, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced preclinical data from CDX-622, the Company�...

May 15, 2023, 12:01 pm

Adaptive biotechnologies announces fda acceptance of genentech’s investigational new drug application for the first neoantigen-directed t-cell therapy product in oncology

The T-Cell Therapy product candidate contains a neoantigen-specific T-cell receptor (TCR) identified an...

May 9, 2023, 11:30 am

Akero therapeutics: proof of concept with efx, sets up catalyst opportunities in 2023

Akero Therapeutics has a proof of concept in using EFX for the treatment of patients with NASH Fibrosis established in the phase 2b HARMONY study. Res...

May 9, 2023, 4:37 am

Olema oncology announces upcoming poster presentation at the 2023 esmo breast cancer annual congress

SAN FRANCISCO, May 08, 2023 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage bio...

May 8, 2023, 11:06 am

Arvinas and pfizer announce upcoming vepdegestrant (arv-471) poster presentations at the 2023 european society for medical oncology (esmo) breast cancer annual congress

NEW HAVEN, Conn. and NEW YORK, May 08, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced they will pr...

May 8, 2023, 11:00 am

Alaunos therapeutics to report first quarter 2023 financial results on may 10, 2023

HOUSTON, May 03, 2023 (GLOBE NEWSWIRE) — Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a leading T-cell ...

May 3, 2023, 12:30 pm

Tscan therapeutics announces upcoming trial in progress poster presentation at the american society of gene and cell therapy 26th annual meeting

Company to host a virtual event to discuss highlights from its Phase 1 umbrella trial of TSC-100 and TSC-101 on Wednesday, May 17, 2023, at 5:30 p.m. ...

May 2, 2023, 8:42 pm

Tempest announces tpst-1495 poster presentation at the 2023 asco annual meeting

BRISBANE, Calif., April 26, 2023 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in...

April 26, 2023, 10:41 pm


Search within

Pages Search Results: